Algert Global’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Sell |
372,238
-39,187
| -10% | -$133K | 0.03% | 756 |
|
|
2025
Q1 | $1.65M | Buy |
411,425
+60,510
| +17% | +$243K | 0.04% | 655 |
|
|
2024
Q4 | $2.28M | Buy |
350,915
+21,540
| +7% | +$140K | 0.05% | 562 |
|
|
2024
Q3 | $1.83M | Buy |
329,375
+34,100
| +12% | +$189K | 0.05% | 579 |
|
|
2024
Q2 | $1.65M | Buy |
295,275
+168,665
| +133% | +$941K | 0.05% | 525 |
|
|
2024
Q1 | $850K | Buy |
126,610
+14,350
| +13% | +$96.3K | 0.03% | 654 |
|
|
2023
Q4 | $1.02M | Buy |
+112,260
| New | +$1.02M | 0.04% | 613 |
|
|
2023
Q2 | – | Sell |
-25,679
| Closed | -$236K | – | 1116 |
|
|
2023
Q1 | $236K | Sell |
25,679
-47,634
| -65% | -$438K | 0.01% | 994 |
|
|
2022
Q4 | $749K | Buy |
73,313
+27,258
| +59% | +$278K | 0.04% | 681 |
|
|
2022
Q3 | $678K | Buy |
46,055
+24,785
| +117% | +$365K | 0.04% | 706 |
|
|
2022
Q2 | $228K | Buy |
+21,270
| New | +$228K | 0.02% | 989 |
|